Eloxx Pharmaceuticals Names T.R. Srinivas Chief Medical Officer
- Eloxx Pharmaceuticals appointed a former Novartis U.S. medical affairs leader as senior vice president and chief medical officer in October 2026.
- Geno Germano joined the board effective October 19, 2026.
- Germano most recently served as president and chief executive officer of Elucida Oncology, with more than 35 years of biopharmaceutical leadership experience.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eloxx Pharmaceuticals Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: NE98242) on November 16, 2026, and is solely responsible for the information contained therein.